Dr
Achim
Krebs

Partner & Patent Attorney

The Hague Office

Chemistry

Telephone. +31(0) 702 400 899
Mobile. +31(0) 615 364 665
Email. [email protected]

Experience

Achim's practice covers a wide range of chemical, pharmaceutical and high tech inventions, and he is acting for a diverse range of companies across these technologies, from start-ups to multinationals.

Achim regularly advises clients on the IP aspects of complex technologies, and on the creation and management of cost-effective IP portfolios.

He also regularly represents clients in Opposition and Appeal Proceedings before the European Patent Office, and often supports clients in multi-jurisdictional contentious situations.

Another field involves due diligence investigations into IP portfolios of technology companies, primarily for venture capital and private equity investors.

Achim is presently serving as President of the LES Benelux.

Achim is qualified as a Dutch, Belgian and European Patent Attorney, and he is a registered European Trade Mark and Design Attorney.

Qualifications

Patent Attorney

Dutch
Europe
Belgian

Trade Mark Attorney

Europe


PHD

Dr. Rer. Nat.

POSTGRADUATE DIPLOMA OR CERTIFICATE

CEIPI Patent Litigation

POSTGRADUATE DIPLOMA OR CERTIFICATE

Polymer RSC

OTHER

Dipl. Chem.

Recognition

IAM Patent 1000

"Achim Krebs appreciates what clients really need and gives made-to-measure advice. He is strategic and has a strong commercial understanding of intellectual property and how it can be used to serve business purposes.” He protects chemical, pharmaceutical and mechanical inventions from his base at HGF in The Hague.

View recognition online

Publications

IAM Global Patent Prosecution 2023

View publication online

IAM Patent 1000 2022

View publication online

IAM Patent 1000 2020

View publication online

IAM Patent 1000 2019

View publication online

Chair WIPO ADR Seminar

View publication online

LES China and CNIPA Licensing Courses 2017 to 2019

Conferences: 2022

October 25th 2022

Webinar: Litigating in the Unified Patent Court

Speaker

Event details

March 7th 2022

IQPC Global Exchange Europe 2022

Attended

Event details

Conferences: 2020

October 12th 2020

LES Benelux Licensing Course 2018

Speaker

Event details

Conferences: 2019

November 4th 2019

LES Benelux Licensing course 2019 - The Hague

Speaker

Event details

Conferences: 2016

April 21st 2016

Topic Meeting IP & Tax – Quo Vadis!

Speaker

Conferences: 2013

September 6th 2013

Conference on Green Technologies - IP, Technology Transfer and Dispute Resolution in the Energy Sector

Speaker

Event details

Conferences: 2012

March 22nd 2012

Thomson Reuters IP Seminar

Speaker

Event details

CSR

President of the Licensing Executive Society for the Benelux for 2020/2021. Secretary LES Benelux 2008-2018.

Related News

Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Parallel importation of pharmaceuticals – when is repackaging necessary?

The repackaging of pharmaceutical products by parallel importers is a long debated subject. The above question was reconsidered in a set of judgements by the CJEU in November last year …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

Trade mark protection for digital health products

The use and creation of digital healthcare products is on the rise as companies look to create a unique selling point and a differentiator in a crowded market. One of …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.